Cairo – The public and private offerings of Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) have been executed on 376.6 million shares, representing 48.99% of the company’s capital shares, at EGP 4.66 per share on the Egyptian Exchange (EGX).
The pharmaceuticals company has raised a total of EGP 1.754 billion through its public and private offerings, according to a bourse statement on Sunday.
The public offering included 18.8 million shares, or 2.45% of the company’s capital shares, valued at EGP 87.7 million, while the private offering involved 357.77 million shares, representing 46.54% of the company’s capital shares, at a value of EGP 1.667 billion.
Rameda’s stock will start trading on the Egyptian Exchange (EGX) on 11 December.
The public offering was oversubscribed by about 36 times, while the private offering was oversubscribed by 117%.
All Rights Reserved - Mubasher Info © 2005 - 2019 Provided by SyndiGate Media Inc. (Syndigate.info).